CardiacSense For Profit
CardiacSense is a company that offers a medical-grade watch for continuous detection of atrial fibrillation, hypertension, and other heart-related issues. The watch provides constant monitoring and accurate results with 99% sensitivity and 99% specificity in distinguishing atrial fibrillation (AF) from sinus rhythm. The company has received regulatory approval from the Israeli Ministry of Health, FDA clearance, and CE Mark for marketing and sales of the CardiacSense medical watch in the European Union. They have also signed a $32.4m medical watch Indian deal. Contact_info: info@cardiacsense.com, support@cardiacsense.com.
Funding Status:
Early Stage Venture
Headquarters:
Caesarea, Hefa, Israel
Founded Date:
2009-12-29
Employee Number:
11-50
Last Funding Type:
Venture - Series Unknown
Estimated Revenue:
<$1M
Industry:
Clinical Data Management
Investors Number:
1
Technology:
Biomarker panels
Investor Type:
For Profit
Last Funding Date:
2019-03-31